---
title: "Procter & Gamble Health Ltd (PGHL) — Share Price, Financials & Analysis"
symbol: "PGHL"
company: "Procter & Gamble Health Ltd"
canonical: "https://tapetide.com/stocks/PGHL"
isin: "INE199A01012"
nse_symbol: "PGHL"
bse_code: "500126"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 8986.08
generated_at: "2026-09-13T19:02:24.948Z"
---

# Procter & Gamble Health Ltd (PGHL)

Canonical page: https://tapetide.com/stocks/PGHL

## Company

- **NSE Symbol:** PGHL
- **BSE Code:** 500126
- **ISIN:** INE199A01012
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1996-04-24
- **CEO:** Mr. Milind Vasant Thatte M.B.A.
- **Employees:** 1326
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** pghealthindia.com

## About

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.[1]

## Latest Price

- **Price:** ₹5411.5
- **Change:** -14 (-0.26%)
- **Open:** ₹5430
- **Day High:** ₹5470.5
- **Day Low:** ₹5302.5
- **Previous Close:** ₹5425.5
- **Volume:** 7707
- **As Of:** 2026-09-11T10:21:49+00:00

## Key Fundamentals

Observed at 2026-09-11T04:46:45.566897Z.

- **Market Cap:** ₹8986.08 Cr
- **Classification:** Microcap
- **P/E (reported):** 25.2
- **P/E (TTM):** 25.17
- **EPS (TTM):** ₹214.99
- **EPS (reported):** ₹128.93
- **Book Value:** ₹316.01
- **Price to Book:** 17.16
- **Dividend Yield:** 3.78%
- **ROE:** 62.32%
- **ROCE:** 76.81%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹1425.3 Cr
- **Net Income:** ₹326.9 Cr
- **EBITDA:** ₹474 Cr
- **52-Week High:** ₹6975
- **52-Week Low:** ₹4707
- **RSI (14):** 26.44

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 84.11 | 9% |
| growth | 41.24 | 9% |
| momentum | 40.24 | 12% |
| ownership | 37.45 | 24% |
| quality | 66.77 | 22% |
| valuation | 67.54 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 42.6%
- Company has been maintaining a healthy dividend payout of 87.1%

### Weaknesses

- Stock is trading at 17.1 times its book value
- The company has delivered a poor sales growth of 0.76% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 100.24% | 47.97% | 99.26% |
| ebitda margin growth | -3.08% | -4.43% | 20.68% | 33.52% |
| net income growth | 1.69% | 39.46% | 19% | 5% |
| revenue growth | 6.65% | 50.91% | 8% | 1% |
| roce | — | 42.5% | 61.3% | 51.3% |
| roe | — | 42.74% | 47.77% | 99.55% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 305 | 310 | 252 | 284 | 313 | 310 | 311 | 339 | 325 | 374 | 370 | 364 |
| Expenses | 216 | 208 | 185 | 236 | 199 | 186 | 230 | 248 | 205 | 263 | 235 | 264 |
| Operating Profit | 89 | 102 | 67 | 48 | 114 | 123 | 81 | 90 | 120 | 110 | 136 | 100 |
| OPM % | 29 | 33 | 27 | 17 | 36 | 40 | 26 | 27 | 37 | 30 | 37 | 27 |
| Other Income | 6 | 5 | 2 | -18 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | 36 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 6 | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before tax | 88 | 100 | 63 | 23 | 111 | 122 | 79 | 89 | 119 | 109 | 133 | 129 |
| Tax % | 26 | 28 | 26 | 26 | 26 | 25 | 22 | 25 | 26 | 29 | 29 | 26 |
| Net Profit | 66 | 72 | 47 | 17 | 82 | 91 | 61 | 66 | 89 | 78 | 95 | 96 |
| EPS in Rs | 39.5 | 43.42 | 28.05 | 10.11 | 49.6 | 54.76 | 36.86 | 39.87 | 53.34 | 46.74 | 56.99 | 57.92 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2018 | Dec 2019 | Jun 2020 18m | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 849 | 927 | 1356 | 1009 | 1114 | 1230 | 1151 | 934 | 1408 | 1433 |
| Expenses | 701 | 723 | 1037 | 762 | 846 | 905 | 845 | 616 | 949 | 967 |
| Operating Profit | 148 | 204 | 319 | 246 | 268 | 325 | 307 | 319 | 459 | 466 |
| OPM % | 17 | 22 | 24 | 24 | 24 | 26 | 27 | 34 | 33 | 33 |
| Other Income | 768 | 48 | 66 | 18 | 13 | 18 | -5 | 10 | 15 | 49 |
| Interest | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
| Depreciation | 21 | 17 | 29 | 30 | 27 | 28 | 27 | 17 | 24 | 24 |
| Profit before tax | 895 | 234 | 355 | 233 | 253 | 314 | 273 | 312 | 450 | 490 |
| Tax % | 6 | 32 | 28 | 24 | 24 | 27 | 26 | 25 | 27 | — |
| Net Profit | 839 | 159 | 254 | 177 | 193 | 229 | 201 | 234 | 327 | 357 |
| EPS in Rs | 505.27 | 95.64 | 153.07 | 106.51 | 115.98 | 138.24 | 121.08 | 141.22 | 196.94 | 214.99 |
| Dividend Payout % | 87 | 0 | 150 | 122 | 45 | 69 | 215 | 89 | 104 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2017 | Dec 2018 | Dec 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 717 | 1524 | 800 | 890 | 687 | 600 | 734 | 522 | 520 | 508 |
| Borrowings | 0 | 0 | 0 | 0 | 8 | 3 | 12 | 10 | 8 | 9 |
| Other Liabilities | 258 | 219 | 250 | 269 | 275 | 269 | 338 | 247 | 250 | 308 |
| Total Liabilities | 991 | 1759 | 1067 | 1176 | 986 | 888 | 1101 | 794 | 794 | 841 |
| Fixed Assets | 115 | 104 | 101 | 101 | 104 | 112 | 144 | 128 | 116 | 102 |
| CWIP | 9 | 17 | 11 | 21 | 39 | 41 | 32 | 6 | 11 | 14 |
| Investments | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 797 | 1639 | 954 | 1053 | 843 | 736 | 925 | 660 | 667 | 726 |
| Total Assets | 991 | 1759 | 1067 | 1176 | 986 | 888 | 1101 | 794 | 794 | 841 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2017 | Dec 2018 | Dec 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 54 | -130 | — | 235 | 247 | 170 | 236 | 228 | 169 | 338 |
| Cash from Investing Activity | -48 | 1270 | — | 165 | -32 | -26 | -22 | -7 | 10 | 1 |
| Cash from Financing Activity | -22 | -30 | — | -883 | -387 | -289 | -98 | -418 | -235 | -344 |
| Net Cash Flow | -16 | 1109 | — | -483 | -172 | -145 | 116 | -197 | -56 | -5 |
| Free Cash Flow | 24 | -157 | — | 212 | 196 | 132 | 198 | 207 | 168 | 323 |
| CFO/OP | 147 | 117 | — | 106 | 128 | 87 | 100 | 102 | 78 | 96 |

### Ratios

| Item | Dec 2017 | Dec 2018 | Dec 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 64 | 28 | 30 | 26 | 22 | 27 | 34 | 27 | 57 | 43 |
| Inventory Days | 243 | 154 | 139 | 113 | 138 | 124 | 136 | 120 | 152 | 137 |
| Days Payable | 128 | 124 | 106 | 105 | 209 | 185 | 239 | 184 | 239 | 192 |
| Cash Conversion Cycle | 179 | 58 | 63 | 34 | -49 | -34 | -69 | -37 | -30 | -13 |
| Working Capital Days | 94 | 42 | 22 | 23 | 7 | 17 | 15 | 19 | 48 | 30 |
| ROCE % | 16 | 78 | 20 | 29 | 29 | 38 | 45 | 45 | 48 | 84 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FIIs | 7.38% | 7.59% | 6.24% | 6.4% | 6.61% | 7.02% | 6.87% | 6.99% | 7.24% | 6.97% | 6.2% | 6.33% |
| DIIs | 12.13% | 12.67% | 13.73% | 14.55% | 14.84% | 14.71% | 14.21% | 14.16% | 13.91% | 13.84% | 13.68% | 12.44% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 23.43% | 22.91% | 22.61% | 21.82% | 21.46% | 21.34% | 21.9% | 21.89% | 22.15% | 22.43% | 23.17% | 23.56% |
| Others | 5.24% | 5.02% | 5.6% | 5.41% | 5.28% | 5.12% | 5.21% | 5.14% | 4.89% | 4.94% | 5.14% | 5.85% |
| No. of Shareholders | 57919 | 56730 | 56778 | 55923 | 54792 | 53736 | 53993 | 52478 | 50006 | 49302 | 50883 | 49056 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 5621.3 | Sell |
| EMA (10) | 5586.91 | Sell |
| SMA (20) | 5709.75 | Sell |
| EMA (20) | 5726.43 | Sell |
| SMA (50) | 6184.48 | Sell |
| EMA (50) | 5941.18 | Sell |
| SMA (100) | 5981.82 | Sell |
| EMA (100) | 5915.68 | Sell |
| SMA (200) | 5638.68 | Sell |
| EMA (200) | 5791.5 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 26.03 | Buy |
| MACD (12,26,9) | -181.36 | Sell |
| Stochastic (14,3,3) | 9.33 | Buy |
| ADX (14) | 40.31 | Buy |
| Williams %R (14) | -81.13 | Buy |
| ATR (14) | 130.56 | Neutral |
| ROC (12) | -6.15 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 37.55 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 1 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 1 analyst ratings, observed at 2026-09-11T04:46:45.641829+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf95bdd-5128-4e74-bb99-0de33aacb96f.pdf) |
| 2026-09-04 | [Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e9f0351-7889-4fab-8398-a7f79ca46c27.pdf) |
| 2026-09-03 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f47b379a-c373-49b8-af46-df7fa1c6ad9e.pdf) |
| 2026-08-12 | [Notice Calling The 59Th Annual General Meeting Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0dc3c8c-1f89-43ed-8507-e5d21febc38e.pdf) |
| 2026-08-12 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e67ccf8c-e660-4723-b9bd-e3cc192da2ab.pdf) |
| 2026-08-12 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=710d3270-e651-4cdf-90c2-4acc02fc33fe.pdf) |
| 2026-08-12 | [59Th Annual General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e453fb27-b9b1-4fbf-b58a-87bb1cc5f541.pdf) |
| 2026-08-10 | [Record Date For Purpose Of Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e4ae256-d1fa-48a7-9329-fe1f9698d770.pdf) |
| 2026-08-06 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a74f498-68c4-4a1b-9214-d9c5327e14ab.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=169e2618-0925-41ed-9630-b07664f7d1e5.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f996346-2b62-418e-8faa-74b0cf5b8d4e.pdf) |
| 2026-05-26 | [Outcome Of The Board Meeting Held On May 26 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4af2320f-41d2-46ea-8b3e-0773e05a915a.pdf) |
| 2026-02-06 | [Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f01b6c9-e46b-4a88-b78a-69ffa47fe028.pdf) |
| 2025-11-05 | [Outcome Of Board Meeting For The Quarter Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b7cfb5b-767b-4d7b-9ad9-c8385996285b.pdf) |
| 2025-08-01 | [Unaudited Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=942ea25f-053a-4056-9304-c75387c91273.pdf) |
| 2025-05-29 | [Financial Results For The Year Ended March 312025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2893bdf6-45c1-42f8-a9c9-aa47085adfd0.pdf) |
| 2025-02-12 | [Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78f7af59-5e27-481d-9a4c-897eeac53485.pdf) |
| 2024-11-04 | [Board Meeting Outcome for Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=514ee540-1208-494d-81ec-5b51da3d003b.pdf) |
| 2024-11-04 | [For The Quarter Ended September 30,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e1b6206-7cf0-44ee-8802-a68adc42c3cf.pdf) |
| 2024-08-21 | [Financial Results For The Financial Year Ended June 30,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfe48ce8-211d-4fd2-be38-884b94fd16d6.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - Q3 sales ₹368 crore (+21%), PAT ₹78 crore; interim dividend ₹160/share (₹50 special). | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 6 Feb - Q3 sales ₹368 crore (+21%), PAT ₹78 crore; interim dividend ₹160/share (₹50 special).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d042cad-59c7-4cd0-bb14-679b077e7ebd.pdf) |
| 6 Feb - Interim dividend Rs.160/share (incl. Rs.50 special); record date Feb 12, 2026; TDS guidance and Feb 10 document deadline | [Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited 6 Feb - Interim dividend Rs.160/share (incl. Rs.50 special); record date Feb 12, 2026; TDS guidance and Feb 10 document deadline](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c33edce7-3341-405a-b430-eeb3a3ee2584.pdf) |
| 6 Apr - P&G Health says it is not a Large Corporate under SEBI circular; outstanding borrowing nil as of 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 6 Apr - P&G Health says it is not a Large Corporate under SEBI circular; outstanding borrowing nil as of 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9ff332c-7a07-4560-9e86-97c2054ec103.pdf) |
| 6 Apr - Dear Sir/Madam, Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Dear Sir/Madam, Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4cf6aa40-04f6-4208-a3d3-a015975f81c9.pdf) |
| 30 Apr - Company executed sale of Mumbai immovable properties, expecting about INR 32 crore profit. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Sale Of Immovable Properties 30 Apr - Company executed sale of Mumbai immovable properties, expecting about INR 32 crore profit.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4354edba-2550-47ea-9460-9fb73f43d168.pdf) |
| 30 Apr - Company executed sale of Mumbai immovable properties, expecting about INR 32 crore profit. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Sale Of Immovable Properties 30 Apr - Company executed sale of Mumbai immovable properties, expecting about INR 32 crore profit.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4354edba-2550-47ea-9460-9fb73f43d168.pdf) |
| 27 Mar - Board meeting on May 26, 2026 to approve FY2026 audited statements and consider final dividend. | [Board Meeting Intimation for Intimation Of Board Meeting 27 Mar - Board meeting on May 26, 2026 to approve FY2026 audited statements and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f2028221-6498-4e85-bf95-bf986b75047c.pdf) |
| — | [Closure of Trading Window 27 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/929be50a-4d16-4ed5-892b-a74d5471a18d.pdf) |
| — | [Corporate Action-Board approves Dividend 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9bc8cd6c-857a-4bfe-a7a3-d3d00e13eb41.pdf) |
| — | [Unaudited Financial Results For The Quarter Ended December 31, 2025 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6f01b6c9-e46b-4a88-b78a-69ffa47fe028.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_3183_MERCK_2013_2013_24022014152959.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e67ccf8c-e660-4723-b9bd-e3cc192da2ab.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab35e3af-c8dd-43b2-acc0-90aa8abb6a08.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ac264b0-e247-44f8-9318-31d682e2fda3.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/884beb99-eae2-4038-827d-7d1d9b2b0d27.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/18ede434-beb4-4484-8793-9ef7916748f0.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500126/72641500126.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500126/67431500126.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2019/MERCK_LTD-500126-DECEMBER-2019.PDF) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500126/5001261218.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e05df49b-0d25-47e5-af2e-c618b21817e2.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e05df49b-0d25-47e5-af2e-c618b21817e2.pdf) |
| May 2018 | [Concall - May 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b0d0bc7-acc4-4df6-a961-f64967661083.pdf) |
| May 2018 | [Concall - May 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/5/1b0d0bc7-acc4-4df6-a961-f64967661083.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a6c27ed-7f8b-4f77-9c6c-1831377c22bf.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8a6c27ed-7f8b-4f77-9c6c-1831377c22bf.pdf) |
| Dec 2023 | [Concall - Dec 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20e95e90-f6c9-4fbf-ba70-abcf726d6b78.pdf) |
| Dec 2023 | [Concall - Dec 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/20e95e90-f6c9-4fbf-ba70-abcf726d6b78.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:02:24.948Z.